Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.

Saved in:
Bibliographic Details
Title: Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.
Authors: Poon DMC; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Comprehensive Oncology Centre, Hong Kong Sanatorium and Hospital, Hong Kong, Hong Kong SAR, China., Tan GM; Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Chan K; Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong SAR, China., Chan MTY; Division of Urology, Department of Surgery, Tuen Mun Hospital, Hong Kong, Hong Kong SAR, China., Chan TW; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, Hong Kong SAR, China., Kan RWM; eFLO Urology, Hong Kong, Hong Kong SAR, China., Lam MHC; Hong Kong Integrated Oncology Centre, Hong Kong, Hong Kong SAR, China., Leung CLH; Department of Surgery, Kwong Wah Hospital, Hong Kong, Hong Kong SAR, China., Wong KCW; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Kam KKH; Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Ng CF; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Chiu PKF; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Source: Frontiers in oncology [Front Oncol] 2024 Jan 31; Vol. 14, pp. 1345322. Date of Electronic Publication: 2024 Jan 31 (Print Publication: 2024).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2024.1345322